Ksenija Yeeles

I joined the Immune Psychosis group at the University of Oxford in 2016 to investigate the role of neuroimmune system in psychosis. My current research with the SINAPPS group aims to find evidence of possible neuroimmune causes and new treatments for psychosis.  I am particularly interested in the improvement of rigours research methodology; mainly clinical randomised controlled trials in the investigation of the effectiveness of new interventions for patients with severe mental health disorders such as psychosis. In the SINAPPS Research Group, we are committed to screening a large number of patients with psychosis for anti-neuronal membrane antibodies across the UK (PPiP2 study) and investigate whether immunotherapy is effective for people with these antibodies (SINAPPS2 trial).

My other research interests were pursued within the Social Psychiatry group in Oxford which I joined in 2007. I researched the use of treatment pressures including informal (ULTIMA study) and formal coercion (OCTET), financial incentives to improve adherence to treatment in community mental health care (FIAT) and a modified programme for employment support (IPS-LITE).  

Previously I worked at the Unit for Social and Community Psychiatry, Queen Mary University of London where I investigated outcomes of involuntary hospital admission in England (InvolvE) and the impact of social and health care interventions on long-term clinical and social outcomes of people with an experience of war (CONNECT).